Skip to main content
Samuel Silver, MD, Hematology, Ann Arbor, MI, University of Michigan Medical Center

SamuelMSilverMDPhD, MACP, FRCP, FAHA, FASCO

Hematology • Ann Arbor, MI

University of Michigan Medical School and Rogel Cancer Center

Join to view full profile

Dr. Silver is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Silver's full profile

Already have an account?

Summary

  • Dr. Samuel Silver is a hematologist in Ann Arbor, MI and is affiliated with Michigan Medicine. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 38 years. He is experienced in hematologic oncology, hematopoietic stem cell transplantation, bone marrow transplantation, porphyria and hematology.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1982 - 1986
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1980 - 1982
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 1979 - 1980
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1979, MD
  • Rockefeller University
    Rockefeller UniversityPhD, Virology , 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - Present
  • MI State Medical License
    MI State Medical License 1986 - 2026
  • PA State Medical License
    PA State Medical License 1982 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Lifetime Achievement Award American College of Physicians, Michigan Chapter, 2023
  • Castle Connolly America’s Top Doctors 2009-2023
  • Lifetime Achievement Award Michigan Society of Hematology/Oncology, 2021
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria  
    Manisha Balwani, M.D., Eliane Sardh, M.D., Ph.D., Paolo Ventura, M.D., Paula Aguilera Peiró, M.D., David C. Rees, F.R.C.P., Ulrich Stölzel, M.D., D. Montgomery Bissell..., New England Journal of Medicine, 6/11/2020
  • The devil’s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda  
    B Sunkara, D Roofeh, S Silver, T LeBleu Pearson, M Ettel and WJ McCune, Lupus (2018) 27, 1383–1386, 2018
  • Change in rate-determining steps for a simple carbonyl addition reaction. Kinetically significant proton transfer step in acid-catalyzed O-methyloxime formation.  
    Silver SM and Sayer JM, J Amer Chem Soc
  • Join now to see all

Books/Book Chapters

  • Studies on the structure and functions of paramyxovirus glycoproteins. 
    Chapter: Negative Strand Viruses and the Host Cell 
    Page 181 - 193Scheid A, Graves MC, Silver SM and Choppin PWEditors: BWJ Mahy and RD Barry.Academic Press, London
  • Bone Marrow Transplantation. 
    Chapter: Schmaier A and Petruzzelli LM 
    Page 247 - 258Uberti J, Silver SM, and Ferrara J. LMEditors: Hematology for the Medical Student.Lippincott Williams & Wilkins, Philadelphia

Abstracts/Posters

  • Timing in adjuvant chemotherapy (CTX) initiation among women with breast cancer (BC) at national comprehensive cancer network (NCCN) centers: An analysis from the NC...
    Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis C, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC, ASCO Annual Meeting
  • Use of a 21-gene reverse transcriptase-polymerase chain reaction (RT-PCR) assay to guide therapy in 14 Michigan breast oncology quality initiative (MiBOQI) sites.
    Silver SM, Ali HY, Blayney DW, Caughran J, Herman JG, Pettinga JE, Share D, Mehringer A, Hayes A, Vandergrift JL, Annual Meeting, Chicago, IL, J Clin Oncol
  • Loss on serial passage of rhesus monkey kidney cells and proteolytic activity. Sendai Virus Activation.
    Silver SM, Scheid A and Choppin PW, Am Soc Microbiol
  • Join now to see all

Lectures

  • New “G” Codes. 
    Seventh Annual Meeting of the Hematology/Oncology Carrier Advisory Committee, Washington DC
  • Educating Carriers on Hematology/Oncology Issues. 
    Seventh Annual Meeting of the Hematology/Oncology Carrier Advisory Committee, Washington DC
  • Michigan Breast Oncology Quality Initiative : Extension to Community Practice. 
    Cancer Quality Alliance, Washington, DC
  • Join now to see all

Other

  • Palifermin (A RHUKGF Molecule) is Safe and Well Tolerated in Patients with Hematologic Malignancies (HM) Undergoing High-Dose Chemoradiotherapy (HD-CRT). 
    Blazar, BR, Weisdorf, DJ, DeFor, TE, Goldman, AI, Silver, S, Ferrara, JLM
  • A Breast Cancer Quality Initiative for Community Practices. 
    Halman LJ, Stella P, Hayes A, Share D, Silver SM, Breast Cancer Symposium, ASCO, San Francisco
  • Michigan Breast Oncology Quality Initiative (MiBOQI): A state-wide multidisciplinary breast cancer quality initiative. Concordance with quality measures. 
    Silver SM, Mehringer AM, Hayes A, Blayney DW, Ali H, Vandergrift JL, Breast Cancer Symposium, ASCO, San Francisco
  • Join now to see all

Press Mentions

  • Siteman's Eberlein Named to National Board
    Siteman's Eberlein Named to National BoardApril 7th, 2016

Committees

  • Chair, Board of Directors, Physician Organization of Michigan 2013 - Present
  • Chair, Board of Directors, National Comprehensive Cancer Network 2013 - 2016

Professional Memberships

Hospital Affiliations

Dr. Samuel Silver, Dr. Samuel Silver, MD, Dr. S Silver, Dr. Samuel M Silver